HOLKIRA PAK
ABBVIE CORPORATION
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is HOLKIRA PAK discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that HOLKIRA PAK 50MG 12.5MG 250MG 75MG has been permanently discontinued (last updated August 30, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is HOLKIRA PAK not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02436027
Strength
50MG 12.5MG 250MG 75MG
Dosage Form
KIT TABLET
Route
ORAL
Active Ingredient
RITONAVIR Ombitasvir Dasabuvir Paritaprevir
Compare with another product →
Shortage History
Other Products from ABBVIE CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
35MG · DIN 02246896
150MG · DIN 02316838
35MG · DIN 02370417
0.5% · DIN 01968300
0.4% · DIN 02248722
0.45% · DIN 02369362
0.2% · DIN 02236876
0.15% · DIN 02248151
10MG · DIN 02443910
50UNIT · DIN 02531577
100UNIT · DIN 01981501
200UNIT · DIN 02531585